Centogene N.V. Recorded Big Gain
Centogene N.V. (CNTG:NASDAQ) shot up at $5.26, representing a gain of 14.3%. On Mon, Dec 27, 2021, CNTG:NASDAQ touched a New 2-Week Low of $4.56. The stock got featured on our News Catalysts scanner on Thu, Dec 23, 2021 at 08:45 AM in the 'MISCELLANEOUS' category. From Mon, Dec 13, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
About Centogene N.V. (CNTG:NASDAQ)
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
Top 10 Gainers:
- Insignia Systems, Inc. (ISIG:NASDAQ), 64.82%
- ShiftPixy, Inc. (PIXY:NASDAQ), 43.09%
- Flotek Industries, Inc. (FTK:NYSE), 40.88%
- CPOP (CPOP:NASDAQ), 35.88%
- BSN (BSN:NYSE), 19.06%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 18.01%
- RGC (RGC:NASDAQ), 16.88%
- Unico American Corporation (UNAM:NASDAQ), 14.75%
- Centogene N.V. (CNTG:NASDAQ), 14.35%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 12.38%